Accession number | Gene | Fold | P value |
---|---|---|---|
PI3K/AKT signaling pathway | |||
X75483 | Cyclin A2 | 3.57 | 2.0E−07 |
AK013312 | Cyclin B2 | 2.86 | 1.3E−03 |
NM007659 | Cyclin-dependent kinase 1 | 2.82 | 2.9E−06 |
NM007629 | Cyclin B1/predicted gene 5593 | 2.00 | 7.2E−04 |
AU015121 | Cyclin B1 | 1.96 | 6.2E−03 |
NM009873 | Cyclin-dependent kinase 6 | 1.67 | 1.5E−05 |
NM011146 | Peroxisome proliferator activated receptor gamma | 1.42 | 4.9E−05 |
BM935811 | Integrin alpha 6 | 1.32 | 6.5E−08 |
NM010576 | Integrin alpha 4 | 1.32 | 6.0E−03 |
AF091432 | Cyclin E2 | 1.30 | 2.0E−04 |
NM016756 | Cyclin-dependent kinase 2 | 1.18 | 5.4E−04 |
AF032460 | BCL2-like 11 (apoptosis facilitator) | 1.11 | 1.3E−03 |
NM007634 | Cyclin F | 1.10 | 1.3E−02 |
BB768208 | Serum/glucocorticoid regulated kinase 3 | 1.03 | 6.7E−05 |
NM011905 | Toll-like receptor 2 | 0.93 | 9.8E−03 |
BM120341 | Integrin beta 1 (fibronectin receptor beta) | 0.92 | 5.7E−06 |
NM007633 | Cyclin E1 | 0.88 | 1.4E−02 |
NM008396 | Integrin alpha 2 | 0.84 | 3.4E−03 |
NM016746 | Cyclin C | 0.73 | 5.7E−06 |
BC003828 | RAS-related C3 botulinum substrate 1 | 0.70 | 1.0E−06 |
NM023243 | Cyclin H | 0.67 | 8.5E−09 |
U95826 | Cyclin G2 | 0.62 | 1.7E−04 |
BB051001 | Cyclin J | 0.61 | 8.4E−04 |
BG070845 | Cyclin-dependent kinase 12 | 0.60 | 1.1E−02 |
NM009870 | Cyclin-dependent kinase 4 | 0.58 | 2.1E−05 |
BB623587 | Integrin alpha 8 | 0.57 | 2.2E−02 |
NM011083 | Phosphatidylinositol 3-kinase | 0.54 | 1.1E−05 |
AF185285 | Toll-like receptor 4 | 0.50 | 1.0E−02 |
NM133721 | Integrin alpha 9 | 0.41 | 1.7E−02 |
NM010761 | Cyclin D-type binding-protein 1 | 0.38 | 5.4E−03 |
AF124142 | Thymoma viral proto-oncogene 3 | 0.35 | 1.4E−02 |
BG065754 | Cyclin G1 | 0.32 | 1.8E−03 |
Regulation of Actin Cytoskeleton | |||
NM011146 | Peroxisome proliferator activated receptor gamma | 1.42 | 4.9E−05 |
BM238906 | NCK associated protein 1 like | 0.86 | 2.3E−02 |
BC027242 | Vav 3 oncogene | 0.74 | 7.7E−03 |
BE372352 | ARP3 actin-related protein 3 | 0.55 | 8.4E−07 |
NM011083 | Phosphatidylinositol 3-kinase | 0.54 | 1.1E−05 |
NM011072 | Profilin 1 | 0.54 | 2.9E−02 |
AW537308 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.36 | 1.4E−02 |
AK014859 | ARP2 actin-related protein 2 | 0.33 | 2.2E−05 |
Focal Adhesions | |||
BM935811 | Integrin alpha 6 | 1.32 | 6.5E−08 |
NM010576 | Integrin alpha 4 | 1.32 | 6.0E−03 |
NM009008 | RAS-related C3 botulinum substrate 2 | 1.21 | 8.8E−04 |
BM246972 | RAS related protein 1b | 1.19 | 7.5E−09 |
BM940281 | Mitogen-activated protein kinase 8 | 0.96 | 4.1E−04 |
BM120341 | Integrin beta 1 (fibronectin receptor beta) | 0.92 | 5.7E−06 |
NM008396 | Integrin alpha 2 | 0.84 | 3.4E−03 |
BC027242 | Vav 3 oncogene | 0.74 | 7.7E−03 |
BC003828 | RAS-related C3 botulinum substrate 1 | 0.70 | 1.0E−06 |
BB623587 | Integrin alpha 8 | 0.57 | 2.2E−02 |
NM011083 | Phosphatidylinositol 3-kinase | 0.54 | 1.1E−05 |
NM011949 | Mitogen-activated protein kinase 1 | 0.51 | 3.2E−05 |
BC011105 | RAS-related protein-1a | 0.47 | 8.0E−04 |
NM133721 | Integrin alpha 9 | 0.41 | 1.7E−02 |
AW537308 | p21 protein (Cdc42/Rac)-activated kinase 2 | 0.36 | 1.4E−02 |
AF124142 | Thymoma viral proto-oncogene 3 | 0.35 | 1.4E−02 |
BC015289 | Vasodilator-stimulated phosphoprotein | 0.34 | 2.0E−02 |